SCHEMBL30939785

SCHEMBL30939785

CCCCCOC(=O)C[C@H](N[P@@](=O)(OC[C@H]1CC[C@](C#N)(c2ccc3c(N)ncnn23)O1)Oc1ccc(C(C)(C)C)cc1)C(=O)OCCCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30939831 0.86 TMPRSS2 (0.38) —
SCHEMBL24149678 0.86 DOT1L (0.31) —
SCHEMBL24149370 0.85 DOT1L (0.31) —
SCHEMBL30939787 0.85 TMPRSS2 (0.31) —
SCHEMBL31684149 0.83 TMPRSS2 (0.30) —
SCHEMBL31684175 0.83 TMPRSS2 (0.30) —
SCHEMBL31684129 0.83 TMPRSS2 (0.30) —
SCHEMBL25012918 0.82 DOT1L (0.30) —
SCHEMBL25012695 0.81 — —
SCHEMBL25013598 0.81 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024120464-A1 NUCLEOTIDE ANALOG, AND COMPOSITION AND USE THEREOF 深圳市塔吉瑞生物医药有限公司 2024-06-13 — — WO disclosed
Send feedback